InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

- Current share price for IPD : $0.005

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Appendix 3B 13 Oct 2016 3:42PM $1.583 $0.005 fallen by 99.68%
$18 2016 Annual Report 13 Oct 2016 12:47AM $1.560 $0.005 fallen by 99.68%
$18 Notice of Annual General Meeting and Proxy Form 13 Oct 2016 12:44AM $1.560 $0.005 fallen by 99.68%
$18 Change in substantial holding 12 Oct 2016 6:40PM $1.505 $0.005 fallen by 99.67%
$18 Ceasing to be a substantial holder 7 Oct 2016 4:52PM $1.630 $0.005 fallen by 99.69%
$18 Notification Under Section 708A(5)(e) 30 Sep 2016 8:24AM $1.605 $0.005 fallen by 99.69%
$18 Appendix 3B 30 Sep 2016 8:24AM $1.605 $0.005 fallen by 99.69%
$18 Notification Under Section 708A(5)(e) 23 Sep 2016 8:23AM $1.680 $0.005 fallen by 99.70%
$18 Appendix 3B 23 Sep 2016 8:23AM $1.680 $0.005 fallen by 99.70%
$18 Study on Efficacy of L-Dex in Routine Clinical Practice 14 Sep 2016 9:27AM $1.450 $0.005 fallen by 99.66%
$18 Becoming a substantial holder 12 Sep 2016 5:02PM $1.370 $0.005 fallen by 99.64%
$18 Notification under section 708A(5)(e) 5 Sep 2016 10:14AM $1.480 $0.005 fallen by 99.66%
$18 Appendix 3B 5 Sep 2016 10:13AM $1.480 $0.005 fallen by 99.66%
$18 Change in substantial holding 1 Sep 2016 8:23AM $1.540 $0.005 fallen by 99.68%
$18 Appendix 4G and Corporate Governance Statement 24 Aug 2016 8:22AM $1.625 $0.005 fallen by 99.69%
$18 Annual Financial Report 30 June 2016 24 Aug 2016 8:21AM $1.625 $0.005 fallen by 99.69%
$18 Appendix 4E and Press Release 24 Aug 2016 8:19AM $1.625 $0.005 fallen by 99.69%
$18 Becoming a substantial holder 12 Aug 2016 6:37PM $1.760 $0.005 fallen by 99.72%
$18 SOZO Launched - First Product for Health and Wellness Market 11 Aug 2016 9:54AM $1.540 $0.005 fallen by 99.68%
$18 Ceasing to be a substantial holder 10 Aug 2016 6:48PM $1.540 $0.005 fallen by 99.68%
$18 Initial Director's Interest Notice 10 Aug 2016 11:41AM $1.458 $0.005 fallen by 99.66%
$18 Final Director's Interest Notice 10 Aug 2016 11:38AM $1.458 $0.005 fallen by 99.66%
$18 Scripps to use SOZO in Heart Failure Study 10 Aug 2016 8:28AM $1.450 $0.005 fallen by 99.66%
$18 Final Director's Interest Notice 9 Aug 2016 1:29PM $1.460 $0.005 fallen by 99.66%
$18 FDA Releases Important Information on Digital Health 9 Aug 2016 9:22AM $1.365 $0.005 fallen by 99.63%

976 - 1000 of 1209 results

Page 40 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.